Menu
Menu
Question:
Can a subcutaneous injection of insulin administered to a patient be billed?
Answer:
Subcutaneous injections of insulin may be administered to patients as sliding scale protocol or to correct blood sugar levels; however, per Medicare and most MACs, insulin is considered a self-administered drug, meaning that in most cases the administration of insulin is billed on a hospital claim with charges reported as non-covered. If reporting on a professional claim the injection is not billed. The drug may be billed, but with revenue code 637.
CPT® copyright 2022 American Medical Association (AMA). All rights reserved.
Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
CPT is a registered trademark of the American Medical Association.
Subscribe to receive our News, Insights, and Compliance Question of the Week delivered right to your inbox.
Address: 445 Minnesota Street, Suite 514
St. Paul, MN 55101
Phone: (800) 252-1578
Email: support@medlearnmedia.com
Hours: 9am – 5pm CT
Copyright © 2023 MedLearn Publishing. Powered by MedLearn Media.
